The economy and markets look bullish for the future, and we have some profitable opportunities in today’s The Bull & The Bear.

This week, Adam O’Dell, Green Zone Fortunes co-editor Charles Sizemore and I are back with three more buy recommendations for your portfolio. Two of these companies live within the biotech and pharmaceuticals segment of the market, and the third is one of the biggest banks around.

And all three of these stocks rank at least “Bullish” in our Green Zone Ratings System, with one earning a “Strong Bullish” rating.

One of companies we are recommending today has an 81 rating in our system!

It ranks high in growth (96), quality (75) and momentum (63).

These are three recommendations that we expect to outperform the broader market by at least two times in the next 12 months. And the “Strong Bullish” stock should outperform by three times!

Be sure to also subscribe to our YouTube channel for more videos like my weekly Marijuana Market Update.

Have something you want us to talk about? Email thebullandthebear@moneyandmarkets.com and give us your thoughts.

Check out moneyandmarkets.com, and sign up for our free newsletters that deliver you the most important and unbiased financial news, commentary, and actionable advice.

Also, follow us on:

Facebook

Twitter

LinkedIn